EGFR TKIs plus WBRT Demonstrated No Survival Benefit Other Than That of TKIs Alone in Patients with NSCLC and EGFR Mutation and Brain Metastases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

EGFR TKIs plus WBRT Demonstrated No Survival Benefit Other Than That of TKIs Alone in Patients with NSCLC and EGFR Mutation and Brain Metastases

Published:2016-10 Issue:10 Volume:11 Page:1718-1728
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Jiang Tao,Su Chunxia,Li Xuefei,Zhao Chao,Zhou Fei,Ren Shengxiang,Zhou Caicun,Zhang Jun

Funder

National Natural Science Foundation of China

Shanghai Municipal Commission of Health and Family Planning

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference42 articles.

1. Epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of central nerve system metastases from non-small cell lung cancer;Zhang;Cancer Lett,2014

2. Systemic treatments for brain metastases from breast cancer, non-small cell lung cancer, melanoma and renal cell carcinoma: an overview of the literature;Lombardi;Cancer Treat Rev,2014

3. Brain metastases in patients with non-small cell lung cancer: focus on the role of chemotherapy;Adamo;Ann Oncol,2006

4. The biology of brain metastases-translation to new therapies;Eichler;Nat Rev Clin Oncol,2011

5. CNS metastases in non-small-cell lung cancer: current role of EGFR-TKI therapy and future perspectives;Berger;Lung Cancer,2013

Cited by 112 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Central nervous system metastases in advanced non-small cell lung cancer: A review of the therapeutic landscape;Cancer Treatment Reviews;2024-11

2. Comprehensive analysis of clinicopathological profiles in adenosquamous carcinoma of the lung;American Journal of Translational Research;2024

3. First-line treatment with TKI plus brain radiotherapy versus TKI alone in EGFR-mutated non-small cell Lung cancer with brain metastases: a systematic review and meta-analysis;BMC Cancer;2023-10-30

4. Prognostic value of cranial radiotherapy and optimal timing stratified by lung-molGPA for NSCLC patients with brain metastases;Journal of Neuro-Oncology;2023-08-30

5. Survival outcomes of NSCLC patients with brain metastases stratified by Lung- molGPA and application and timing of cranial radiotherapy;2023-07-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3